In vitro hepatic metabolism of the natural product quebecol

References

• Austin RP, Barton P, Cockroft SL, Wenlock MC, Riley RJ. 2002. The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties. Drug Metab Dispos. 30(12):1497–1503.
   PubMed Web of Science ®Google Scholar
• Ball DW. 2007. The chemical composition of maple syrup. J Chem Educ. 84(10):1647–1650.
   Web of Science ®Google Scholar
• Cardinal S, Azelmat J, Grenier D, Voyer N. 2016. Anti-inflammatory properties of quebecol and its derivatives. Bioorg Med Chem Lett. 26(2):440–444.
   PubMed Web of Science ®Google Scholar
• Cardinal S, Paquet-Côté P-A, Azelmat J, Bouchard C, Grenier D, Voyer N. 2017. Synthesis and anti-inflammatory activity of isoquebecol. Bioorg Med Chem. 25(7):2043–2056.
   PubMed Web of Science ®Google Scholar
• Caspar AT, Meyer MR, Maurer HH. 2018. Human cytochrome P450 kinetic studies on six N-2-methoxybenzyl (NBOMe)-derived new psychoactive substances using the substrate depletion approach. Toxicol Lett. 285:1–8.
   PubMed Web of Science ®Google Scholar
• Chênevert R, Mohammadi-Ziarani G, Caron D, Dasser M. 1999. Chemoenzymatic enantioselective synthesis of (-)-enterolactone. Can J Chem. 77(2):223–226.
   Web of Science ®Google Scholar
• Cummings J, Ethell BT, Jardine L, Boyd G, Macpherson JS, Burchell B, Smyth JF, Jodrell DI. 2003. Glucuronidation as a mechanism of intrinsic drug resistance in human colon cancer: reversal of resistance by food additives. Cancer Res. 63(23):8443–8450.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency 2011. Guideline on bioanalytical method validation. Committee for Medicinal Products for Human Use (CHMP).
   Google Scholar
• Fabregat A, Pozo OJ, Marcos J, Segura J, Ventura R. 2013. Use of LC-MS/MS for the Open Detection of Steroid Metabolites Conjugated with Glucuronic Acid. Anal Chem. 85(10):5005–5014.
   PubMed Web of Science ®Google Scholar
• Giuliano C, Jairaj M, Zafiu CM, Laufer R. 2005. Direct determination of unbound intrinsic drug clearance in the microsomal stability assay. Drug Metab Dispos. 33(9):1319–1324.
   PubMed Web of Science ®Google Scholar
• González-Sarrías A, Li L, Seeram NP. 2012a. Anticancer effects of maple syrup phenolics and extracts on proliferation, apoptosis, and cell cycle arrest of human colon cells. J Funct Foods. 4(1):185–196.
   Web of Science ®Google Scholar
• González-Sarrías A, Li L, Seeram NP. 2012b. Effects of maple (Acer) plant part extracts on proliferation, apoptosis and cell cycle arrest of human tumorigenic and non-tumorigenic colon cells. Phytother Res. 26(7):995–1002.
   PubMed Web of Science ®Google Scholar
• González-Sarrías A, Ma H, Edmonds ME, Seeram NP. 2013. Maple polyphenols, ginnalins A–C, induce S- and G2/M-cell cycle arrest in colon and breast cancer cells mediated by decreasing cyclins A and D1 levels. Food Chem. 136(2):636–642.
   PubMed Web of Science ®Google Scholar
• Hosea NA, Collard WT, Cole S, Maurer TS, Fang RX, Jones H, Kakar SM, Nakai Y, Smith BJ, Webster R, et al. 2009. Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches. J Clin Pharmacol. 49(5):513–533.
   PubMed Web of Science ®Google Scholar
• Jeong H, Kim S, Lee J, Park JY, Zhou W, Liu X, Kim SD, Song YS, Jang C-Y, Oh S-R, et al. 2017. Characterization of phase I and phase II hepatic metabolism and reactive intermediates of Larrea nitida Cav. and its lignan compounds. Phyther Res. 31(1):140–151.
   PubMed Web of Science ®Google Scholar
• Jiang W, Xu B, Wu B, Yu R, Hu M. 2012. UDP-Glucuronosyltransferase (UGT) 1A9-overexpressing HeLa cells is an appropriate tool to delineate the kinetic interplay between breast cancer resistance protein (BCRP) and UGT and to rapidly identify the glucuronide substrates of BCRP. Drug Metab Disposit. 40(2):336–345.
   PubMed Web of Science ®Google Scholar
• Jordan VC. 2003. Tamoxifen: a most unlikely pioneering medicine. Nat Rev Drug Discov. 2(3):205–213.
   PubMed Web of Science ®Google Scholar
• Kim SY, Laxmi YRS, Suzuki N, Ogura K, Watabe T, Duffel MW, Shibutani S. 2005. Formation of Tamoxifen-DNA Adducts Via o-Sulfonation, not o-Acetylation, of α-hydroxytamoxifen in Rat And Human Livers. Drug Metab Dispos. 33(11):1673–1678.
   PubMed Web of Science ®Google Scholar
• Knust U, Hull WE, Spiegelhalder B, Bartsch H, Strowitzki T, Owen RW. 2006. Analysis of enterolignan glucuronides in serum and urine by HPLC-ESI-MS. Food Chem Toxicol. 44(7):1038–1049.
   PubMed Web of Science ®Google Scholar
• Legault J, Girard-Lalancette K, Grenon C, Dussault C, Pichette A. 2010. Antioxidant activity, inhibition of nitric oxide overproduction, and in vitro antiproliferative effect of maple sap and syrup from Acer saccharum. J Med Food. 13(2):460–468.
   PubMed Web of Science ®Google Scholar
• Li L, Seeram NP. 2010. Maple Syrup Phytochemicals Include Lignans, Coumarins, a Stilbene, and Other Previously Unreported Antioxidant Phenolic Compounds. J Agric Food Chem. 58(22):11673–11679.
   PubMed Web of Science ®Google Scholar
• Li L, Seeram NP. 2011. Quebecol, a novel phenolic compound isolated from Canadian maple syrup. J Funct Foods. 3(2):125–128.
   Web of Science ®Google Scholar
• Lien EA, Solheim E, Lea OA, Lundgren S, Kvinnsland S, Ueland PM. 1989. Distribution of 4-Hydroxy-N-desmethyltamoxifen and Other Tamoxifen Metabolites in Human Biological Fluids during Tamoxifen Treatment1. Cancer Res. 49(8):2175–2183.
   PubMed Web of Science ®Google Scholar
• Lin C, Krol ES, Alcorn J. 2013. The Comparison of Rat and Human Intestinal and Hepatic Glucuronidation of Enterolactone Derived from Flaxseed Lignans. Nat Prod J. 3(3):159–171.
   Google Scholar
• Liu W, Wei Z, Ma H, Cai A, Liu Y, Sun J, DaSilva NA, Johnson SL, Kirschenbaum LJ, Cho BP, et al. 2017. Anti-glycation and anti-oxidative effects of a phenolic-enriched maple syrup extract and its protective effects on normal human colon cells. Food Funct. 8(2):757–766.
   PubMed Web of Science ®Google Scholar
• Liu Y, Rose KN, DaSilva NA, Johnson SL, Seeram NP. 2017. Isolation, Identification, and Biological Evaluation of Phenolic Compounds from a Traditional North American Confectionery, Maple Sugar. J Agric Food Chem. 65(21):4289–4295.
   PubMed Web of Science ®Google Scholar
• Nagar S, Argikar UA, Tweedie DJ. 2014. Enzyme kinetics in drug metabolism: fundamentals and applications. Methods Mol Biol. 1113:1–6.
   PubMedGoogle Scholar
• Nahar PP, Driscoll MV, Li L, Slitt AL, Seeram NP. 2014. Phenolic mediated anti-inflammatory properties of a maple syrup extract in RAW 264.7 murine macrophages. J Funct Foods. 6:126–136.
   Web of Science ®Google Scholar
• Nath A, Atkins WM. 2006. A theoretical validation of the substrate depletion approach to determining kinetic parameters. Drug Metab Dispos. 34(9):1433–1435.
   PubMed Web of Science ®Google Scholar
• Nwabufo CK, Aigbogun OP, Allen KJH, Owens MN, Lee JS, Phenix CP, Krol ES. 2021. Employing in vitro metabolism to guide design of F-labelled PET probes of novel α-synuclein binding bifunctional compounds. Xenobiotica. 51(8):885–900.
   PubMed Web of Science ®Google Scholar
• Obach RS, Reed-Hagen AE. 2002. Measurement of Michaelis constants for cytochrome P450-mediated biotransformation reactions using a substrate depletion approach. Drug Metab Dispos. 30(7):831–837.
   PubMed Web of Science ®Google Scholar
• Pericherla K, Shirazi AN, Rao VK, Tiwari RK, DaSilva N, McCaffrey KT, Beni YA, González-Sarrías A, Seeram NP, Parang K, et al. 2013. Synthesis and antiproliferative activities of quebecol and its analogs. Bioorg Med Chem Lett. 23(19):5329–5331.
   PubMed Web of Science ®Google Scholar
• Perkins TD, van den Berg AKBT. 2009. Maple syrup—production, composition, chemistry, and sensory characteristics. Adv Food Nutr Res. 56:101–143.
   PubMedGoogle Scholar
• Rose KN, Barlock BJ, DaSilva NA, Johnson SL, Liu C, Ma H, Nelson R, Akhlaghi F, Seeram NP. 2021. Anti-neuroinflammatory effects of a food-grade phenolic-enriched maple syrup extract in a mouse model of Alzheimer’s disease. Nutr Neurosci. 24(9):710–719.
   PubMed Web of Science ®Google Scholar
• Rowland M, Benet LZ, Graham GG. 1973. Clearance concepts in pharmacokinetics. J Pharmacokinet Pharmacodyn. 1(2):123–136.
   Google Scholar
• Schwaninger AE, Meyer MR, Barnes AJ, Gorelick DA, Goodwin RS, Huestis MA, Maurer HH. 2011. Investigation on the Enantioselectivity of the Sulfation of the Dihydroxymethamphetamine and 4-Hydroxy-3- Methoxymethamphetamine using the Substrate-Depletion Approach. Drug Metab Dispos. 39(11):1998–2002.
   PubMed Web of Science ®Google Scholar
• Starland-Davenport A, Lyn-Cook B, Radominska-Pandya A. 2008. Novel identification of UDP-glucuronosyltransferase 1A10 as an estrogen-regulated target gene. Steroids. 73(1):139–147.
   PubMed Web of Science ®Google Scholar
• Sun D, Sharma AK, Dellinger RW, Blevins-Primeau AS, Balliet RM, Chen G, Boyiri T, Amin S, Lazarus P. 2007. Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases. Drug Metab Dispos. 35(11):2006–2014.
   PubMed Web of Science ®Google Scholar
• U.S Food and Drug Administration 2018. Bioanalytical Method Validation: guidance for Industry. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Veterinary Medicine (CVM).
   Google Scholar
• Uno S, Fujii A, Komura H, Kawase A, Iwaki M. 2008. Prediction of metabolic clearance of diclofenac in adjuvant-induced arthritis rats using a substrate depletion assay. Xenobiotica. 38(5):482–495.
   PubMed Web of Science ®Google Scholar
• Walsky RL, Bauman JN, Bourcier K, Giddens G, Lapham K, Negahban A, Ryder TF, Obach RS, Hyland R, Goosen TC. 2012. Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors. Drug Metab Dispos. 40(5):1051–1065.
   PubMed Web of Science ®Google Scholar
• Wang R, Hartmann MF, Wudy SA. 2021. Targeted LC–MS/MS analysis of steroid glucuronides in human urine. J Steroid Biochem Mol Biol. 205:105774.
   PubMed Web of Science ®Google Scholar
• Wilkinson GR, Shand DG. 1975. A physiological approach to hepatic drug clearance. Clin Pharmacol Ther. 18(4):377–390.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Uemura K, Moriyama K, Mitamura K, Taga A. 2015. Inhibitory effect of maple syrup on the cell growth and invasion of human colorectal cancer cells. Oncol Rep. 33(4):1579–1584.
   PubMed Web of Science ®Google Scholar
• Yang G, Ge S, Singh R, Basu S, Shatzer K, Zen M, Liu J, Tu Y, Zhang C, Wei J, et al. 2017. Glucuronidation: driving factors and their impact on glucuronide disposition. Drug Metab Rev. 49(2):105–138.
   PubMed Web of Science ®Google Scholar
• Youdim K, Dodia R. 2010. Comparison between recombinant P450s and human liver microsomes in the determination of cytochrome P450 Michaelis-Menten constants. Xenobiotica. 40(4):235–244.
   PubMed Web of Science ®Google Scholar